Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q3 2016 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2016-11-14

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $123M (85.7% shares, 14.3% debt)

Holdings (17)

— Tobira Therapeutics, Inc. 23.8%

Value $29.16M Shares 733,718 Est. Cost $13.94 Unrealized —

— Viveve Medical, Inc 15.3%

Value $18.77M Shares 2,599,711 Est. Cost $7.22 Unrealized —

— Aegerion Pharmaceuticals, Inc. 13.0%

Value $15.96M Shares 24,200,000 Est. Cost $0.60 Unrealized —

— Alere Inc. 10.1%

Value $12.39M Shares 286,651 Est. Cost $42.83 Unrealized —

— QLT Inc. 9.7%

Value $11.9M Shares 5,778,496 Est. Cost $1.64 Unrealized —

— Recro Pharma, Inc. 8.4%

Value $10.35M Shares 1,170,600 Est. Cost $8.42 Unrealized —

— Cardiome Pharma Corp 4.9%

Value $6.006M Shares 1,918,722 Est. Cost $3.13 Unrealized —

— Cutera, Inc. 3.9%

Value $4.768M Shares 400,000 Est. Cost $11.59 Unrealized —

VCEL Vericel Corp 2.3%

Value $2.865M Shares 1,023,048 Est. Cost $2.48 Unrealized -7.3%

— Alimera Sciences, Inc 2.3%

Value $2.842M Shares 1,907,190 Est. Cost $1.49 Unrealized —

— Durect Corporation 1.9%

Value $2.288M Shares 1,646,170 Est. Cost $1.38 Unrealized —

CPIX Cumberland Pharmaceuticals, Inc. 1.3%

Value $1.622M Shares 323,747 Est. Cost $4.65 Unrealized +1.0%

— Pernix Therapeutics Holdings 1.3%

Value $1.564M Shares 6,000,000 Est. Cost $0.23 Unrealized —

— Juniper Pharmaceuticals, Inc. 0.8%

Value $966K Shares 173,967 Est. Cost $5.55 Unrealized —

— Aviragen Therapeutics, Inc. 0.5%

Value $667K Shares 347,440 Est. Cost $1.48 Unrealized —

— Derma Sciences, Inc. 0.4%

Value $458K Shares 98,064 Est. Cost $4.57 Unrealized —

PCRX Pacira Pharmaceuticals, Inc. 0.0%

Value $51,000 Shares 1,500 Est. Cost $49.15 Unrealized -20.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Tobira Therapeutics, Inc.	733,718	$29.16M	23.8%	$13.94	—	COM	88883P101
—	Viveve Medical, Inc	2,599,711	$18.77M	15.3%	$7.22	—	COM	92852W204
—	Aegerion Pharmaceuticals, Inc.	24,200,000	$15.96M	13.0%	$0.60	—	NOTE	00767EAB8
—	Alere Inc.	286,651	$12.39M	10.1%	$42.83	—	COM	01449J105
—	QLT Inc.	5,778,496	$11.9M	9.7%	$1.64	—	COM	746927102
—	Recro Pharma, Inc.	1,170,600	$10.35M	8.4%	$8.42	—	COM	75629F109
—	Cardiome Pharma Corp	1,918,722	$6.006M	4.9%	$3.13	—	COM	14159U301
—	Cutera, Inc.	400,000	$4.768M	3.9%	$11.59	—	COM	232109108
VCEL	Vericel Corp	1,023,048	$2.865M	2.3%	$2.48	-7.3%	COM	92346J108
—	Alimera Sciences, Inc	1,907,190	$2.842M	2.3%	$1.49	—	COM	016259103
—	Durect Corporation	1,646,170	$2.288M	1.9%	$1.38	—	COM	266605104
CPIX	Cumberland Pharmaceuticals, Inc.	323,747	$1.622M	1.3%	$4.65	+1.0%	COM	230770109
—	Pernix Therapeutics Holdings	6,000,000	$1.564M	1.3%	$0.23	—	NOTE	71426VAK4
—	Juniper Pharmaceuticals, Inc.	173,967	$966K	0.8%	$5.55	—	COM	48203L107
—	Aviragen Therapeutics, Inc.	347,440	$667K	0.5%	$1.48	—	COM	053761102
—	Derma Sciences, Inc.	98,064	$458K	0.4%	$4.57	—	COM	249827502
PCRX	Pacira Pharmaceuticals, Inc.	1,500	$51,000	0.0%	$49.15	-20.3%	COM	695127100